Invitae to Present at the TD Cowen 43rd Annual Health Care Conference
Invitae (NYSE: NVTA), a prominent medical genetics company, announced that Ken Knight, its president and CEO, will participate in a fireside chat at the TD Cowen 43rd Annual Health Care Conference on March 6, 2023, at 1:30 p.m. Eastern.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Invitae (NYSE: NVTA), a prominent medical genetics company, announced that Ken Knight, its president and CEO, will participate in a fireside chat at the TD Cowen 43rd Annual Health Care Conference on March 6, 2023, at 1:30 p.m. Eastern.
A live audio webcast will be available on the investor section of the company's website, with a replay accessible shortly after the event. Invitae's mission is to integrate comprehensive genetic information into modern healthcare, improving medical decision-making for individuals globally.
Details
News Market Reaction – NVTA
The recorded move for NVTA in the trading session of this news was +8.33%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, March 1, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that Ken Knight, president and chief executive officer, will participate in a fireside chat at the TD Cowen 43rd Annual Health Care Conference on Monday, March 6, at 1:30 p.m. Eastern.
A live audio webcast of the fireside chat may be accessed by visiting the investors section of the company's website at ir.invitae.com. A replay of the webcast will be available shortly after the conclusion of the fireside chat.
About Invitae
Invitae (NYSE: NVTA) is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We aim to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.
To learn more, visit invitae.com and follow for updates on Twitter, Instagram, Facebook and LinkedIn @Invitae.
Contacts for Invitae:
Investor Relations
Hoki Luk
ir@invitae.com
Public Relations
Amy Hadsock
pr@invitae.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/invitae-to-present-at-the-td-cowen-43rd-annual-health-care-conference-301759835.html
SOURCE Invitae Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.